Hepatocyte differentiation, proliferation, and apoptosis are affected by growth factors
produced in liver. Insulin-like growth factor 1 and 2 (IGF1 and IGF2) act in response to …

Background: Hepatocellular carcinoma (HCC) has multiple prognostic factors, and there is
an increase in knowledge about the body composition and physical status of patients with …

Hepatocellular carcinoma (HCC) is a cause of several deaths related to cancer worldwidely.
In early stage, curative treatments such as surgical resection, liver transplant and local …

Determination of the role of insulin-like growth factor (IGF) family components in
carcinogenesis of several human tumors is based on numerous epidemiological and pre …

The incidence of hepatocellular carcinoma (HCC) and HCC-related deaths has increased
over the last few decades. There are several risk factors of HCC such as viral hepatitis (B …

Background & aims Hepatocellular carcinoma (HCC) is the fifth most common malignant
tumor disease in the world. The impact of sarcopenia on survival outcomes in patients with …

Liver diseases and in particular end stage liver diseases are frequently complicated by
muscle modifications that are linked to worse clinical outcome. In addition, recent studies …

Hepatocellular carcinoma (HCC) is the sixth most common cancer in the world and the third
leading cause of cancer-related death. The high rate of diagnosis in non-curable stages and …

Purpose Radiofrequency ablation (RFA) appears effective for the treatment of hepatocellular
carcinoma (HCC). Evaluation of prognostic factors is imperative for patient selection and …

This review provides epidemiological and translational evidence for milk and dairy intake as
critical risk factors in the pathogenesis of hepatocellular carcinoma (HCC). Large …